Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 768

1.

Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis.

Probert PM, Leitch AC, Dunn MP, Meyer SK, Palmer JM, Abdelghany TM, Lakey AF, Cooke MP, Talbot H, Wills C, McFarlane W, Blake LI, Rosenmai AK, Oskarsson A, Figueiredo R, Wilson C, Kass GE, Jones DE, Blain PG, Wright MC.

J Hepatol. 2018 Jul 10. pii: S0168-8278(18)32182-2. doi: 10.1016/j.jhep.2018.06.027. [Epub ahead of print]

2.

Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density.

Graffmann N, Ncube A, Wruck W, Adjaye J.

PLoS One. 2018 Jul 10;13(7):e0200416. doi: 10.1371/journal.pone.0200416. eCollection 2018.

3.

Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2-/- mice by diminishing senescence of cholangiocytes.

Zhou T, Wu N, Meng F, Venter J, Giang TK, Francis H, Kyritsi K, Wu C, Franchitto A, Alvaro D, Marzioni M, Onori P, Mancinelli R, Gaudio E, Glaser S, Alpini G.

Lab Invest. 2018 Jul 5. doi: 10.1038/s41374-018-0093-9. [Epub ahead of print]

PMID:
29977037
4.

Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells.

Zhang C, Li JY, Tian FZ, Zhao G, Hu H, Ma YF, Yang YL.

Oncol Res. 2018 Jul 5;26(6):879-888. doi: 10.3727/096504017X15024935181289.

PMID:
29970216
5.

Co-occurrence of opisthorchiasis and diabetes exacerbates morbidity of the hepatobiliary tract disease.

Chaidee A, Onsurathum S, Intuyod K, Pannangpetch P, Pongchaiyakul C, Pinlaor P, Pairojkul C, Ittiprasert W, Cochran CJ, Mann VH, Brindley PJ, Pinlaor S.

PLoS Negl Trop Dis. 2018 Jun 28;12(6):e0006611. doi: 10.1371/journal.pntd.0006611. eCollection 2018 Jun.

6.

Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.

Hill MA, Alexander WB, Guo B, Kato Y, Patra KC, O'Dell MR, McCall MN, Whitney-Miller CL, Bardeesy N, Hezel AF.

Cancer Res. 2018 Jun 5. pii: canres.1123.2017. doi: 10.1158/0008-5472.CAN-17-1123. [Epub ahead of print]

PMID:
29871934
7.

Aberrant expression of redox regulatory proteins in patients with concomitant primary Sclerosing cholangitis/inflammatory bowel disease.

Petersen DR, Orlicky DJ, Roede JR, Shearn CT.

Exp Mol Pathol. 2018 May 29;105(1):32-36. doi: 10.1016/j.yexmp.2018.05.012. [Epub ahead of print]

PMID:
29852184
8.

Bioengineered bile ducts recapitulate key cholangiocyte functions.

Chen C, Jochems PGM, Salz L, Schneeberger K, Penning LC, van de Graaf SFJ, Beuers U, Clevers H, Geijsen N, Masereeuw R, Spee B.

Biofabrication. 2018 Jun 12;10(3):034103. doi: 10.1088/1758-5090/aac8fd.

PMID:
29848792
9.

BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling.

Chung YH, Huang YH, Chu TH, Chen CL, Lin PR, Huang SC, Wu DC, Huang CC, Hu TH, Kao YH, Tai MH.

Lab Invest. 2018 May 22. doi: 10.1038/s41374-018-0069-9. [Epub ahead of print]

PMID:
29789683
10.

Regulation of bile secretion by calcium signaling in health and disease.

Trampert DC, Nathanson MH.

Biochim Biophys Acta. 2018 May 19. pii: S0167-4889(18)30094-6. doi: 10.1016/j.bbamcr.2018.05.010. [Epub ahead of print] Review.

PMID:
29787781
11.

Isolation of a unique hepatic stellate cell population expressing integrin α8 from embryonic mouse livers.

Ogawa T, Li Y, Lua I, Hartner A, Asahina K.

Dev Dyn. 2018 Jun;247(6):867-881. doi: 10.1002/dvdy.24634. Epub 2018 Apr 23.

PMID:
29665133
12.

Liver fibrosis: Direct antifibrotic agents and targeted therapies.

Schuppan D, Ashfaq-Khan M, Yang AT, Kim YO.

Matrix Biol. 2018 Aug;68-69:435-451. doi: 10.1016/j.matbio.2018.04.006. Epub 2018 Apr 12. Review.

PMID:
29656147
13.

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-/- mice by modulating composition, signalling and excretion of faecal bile acids.

Fuchs CD, Paumgartner G, Mlitz V, Kunczer V, Halilbasic E, Leditznig N, Wahlström A, Ståhlman M, Thüringer A, Kashofer K, Stojakovic T, Marschall HU, Trauner M.

Gut. 2018 Apr 10. pii: gutjnl-2017-314553. doi: 10.1136/gutjnl-2017-314553. [Epub ahead of print]

14.

Expression patterns of Yes-associated protein 1 in the developing mouse liver.

Wei W, Lotto J, Hoodless PA.

Gene Expr Patterns. 2018 Apr 5;29:10-17. doi: 10.1016/j.gep.2018.04.003. [Epub ahead of print]

PMID:
29627454
15.

Direct Conversion of Mouse Fibroblasts into Cholangiocyte Progenitor Cells.

Lim KT, Kim J, Hwang SI, Zhang L, Han H, Bae D, Kim KP, Hu YP, Schöler HR, Lee I, Hui L, Han DW.

Stem Cell Reports. 2018 May 8;10(5):1522-1536. doi: 10.1016/j.stemcr.2018.03.002. Epub 2018 Mar 29.

16.

BILIARY ATRESIA: Clinical and Research Challenges for the 21st Century.

Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, Sokol RJ.

Hepatology. 2018 Mar 31. doi: 10.1002/hep.29905. [Epub ahead of print]

PMID:
29604222
17.

Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.

Kennedy L, Hargrove L, Demieville J, Karstens W, Jones H, DeMorrow S, Meng F, Invernizzi P, Bernuzzi F, Alpini G, Smith S, Akers A, Meadows V, Francis H.

Hepatology. 2018 Mar 30. doi: 10.1002/hep.29898. [Epub ahead of print]

PMID:
29601088
18.

From "Gut Feeling" to Objectivity: Machine Preservation of the Liver as a Tool to Assess Organ Viability.

Watson CJE, Jochmans I.

Curr Transplant Rep. 2018;5(1):72-81. doi: 10.1007/s40472-018-0178-9. Epub 2018 Jan 20. Review.

19.

Role of lactoferrin and its receptors on biliary epithelium.

Mancinelli R, Olivero F, Carpino G, Overi D, Rosa L, Lepanto MS, Cutone A, Franchitto A, Alpini G, Onori P, Valenti P, Gaudio E.

Biometals. 2018 Jun;31(3):369-379. doi: 10.1007/s10534-018-0094-6. Epub 2018 Mar 17.

PMID:
29550924
20.

Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver Regeneration.

Russell JO, Ko S, Saggi HS, Singh S, Poddar M, Shin D, Monga SP.

Am J Pathol. 2018 Jun;188(6):1389-1405. doi: 10.1016/j.ajpath.2018.02.006. Epub 2018 Mar 12.

PMID:
29545201

Supplemental Content

Loading ...
Support Center